Zsófia Sztupinszki
Zsófia Sztupinszki
Boston Children's Hospital
Verified email at childrens.harvard.edu
Title
Cited by
Cited by
Year
A comprehensive overview of targeted therapy in metastatic renal cell carcinoma
Z Mihály, Z Sztupinszki, P Surowiak, B Gyorffy
Current cancer drug targets 12 (7), 857-872, 2012
482012
The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer
AM Szász, Q Li, AC Eklund, Z Sztupinszki, A Rowan, AM Tőkés, B Székely, ...
PloS one 8 (2), e56707, 2013
302013
Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines
Z Pénzváltó, B Tegze, AM Szász, Z Sztupinszki, I Likó, A Szendrői, ...
PloS one 8 (3), e59503, 2013
232013
Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease
NJ Béres, Z Kiss, Z Sztupinszki, G Lendvai, A Arató, E Sziksz, Á Vannay, ...
Digestive and Liver Disease 49 (4), 378-387, 2017
182017
Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors
M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, KM Timms, C Neff, ...
Annals of Oncology 29 (9), 1948-1954, 2018
172018
Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
Z Sztupinszki, B Győrffy
Scientific reports 6, 37169, 2016
152016
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
NJ Birkbak, Y Li, S Pathania, A Greene-Colozzi, M Dreze, ...
Annals of Oncology 29 (4), 903-909, 2018
142018
High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy
S Leé, K Vargová, I Hizoh, Z Horváth, P Gulácsi-Bárdos, Z Sztupinszki, ...
Thrombosis research 133 (2), 257-264, 2014
122014
Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
Z Sztupinszki, M Diossy, M Krzystanek, L Reiniger, I Csabai, F Favero, ...
NPJ breast cancer 4 (1), 1-4, 2018
112018
Dynamic classification using case‐specific training cohorts outperforms static gene expression signatures in breast cancer
B Győrffy, T Karn, Z Sztupinszki, B Weltz, V Müller, L Pusztai
International journal of cancer 136 (9), 2091-2098, 2015
112015
Validation of rnai silencing efficiency using gene array data shows 18.5% failure rate across 429 independent experiments
G Munkácsy, Z Sztupinszki, P Herman, B Bán, Z Pénzváltó, N Szarvas, ...
Molecular Therapy-Nucleic Acids 5, e366, 2016
92016
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
A Fluckiger, R Daillere, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ...
Science 369 (6506), 936-942, 2020
22020
Detection of molecular signatures of homologous recombination deficiency in prostate cancer with or without BRCA1/2 mutations
Z Sztupinszki, M Diossy, M Krzystanek, J Borcsok, MM Pomerantz, V Tisza, ...
Clinical Cancer Research 26 (11), 2673-2680, 2020
22020
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer
S Sharad, AA Dillman, ZM Sztupinszki, Z Szallasi, I Rosner, J Cullen, ...
Oncotarget 11 (4), 362, 2020
22020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
H Duan, S Mansour, R Reed, MK Gillis, B Parent, B Liu, Z Sztupinszki, ...
Journal of Cell Biology 219 (6), 2020
12020
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
S Sharad, ZM Sztupinszki, Y Chen, C Kuo, L Ravindranath, Z Szallasi, ...
Cancers 11 (12), 1995, 2019
12019
Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding …
M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, KM Timms, C Neff, ...
Annals of Oncology 30 (8), 1406-1406, 2019
12019
The genomic imprint of cancer therapies helps timing the formation of metastases
E Németh, M Krzystanek, L Reiniger, D Ribli, O Pipek, Z Sztupinszki, ...
International journal of cancer 145 (3), 694-704, 2019
12019
Strand Orientation Bias Detector (SOBDetector) to remove artifacts from sequencing data of formalin fixed samples
M Diossy, Z Sztupinszki, M Krzystanek, AG Pedersen, AC Eklund, ...
bioRxiv, 386417, 2018
12018
Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens
AM Szász, B Ács, E Ágoston, Z Sztupinszki, AM Tőkés, L Szittya, ...
Orvosi hetilap 154 (16), 627-632, 2013
12013
The system can't perform the operation now. Try again later.
Articles 1–20